AMI Asset Management’s Haemonetics HAE Stock Holding History

AMI Asset Management’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-376,283	Closed	-$13.2M	–	69
2016 Q1	$13.2M	Buy	376,283 +61,855	+20%	+$2M	0.9%	48
2015 Q4	$10.1M	Buy	314,428 +2,213	+0.7%	+$71.8K	0.7%	53
2015 Q3	$10.1M	Buy	312,215 +62,086	+25%	+$2.34M	0.77%	47
2015 Q2	$10.3M	Buy	250,129 +9,195	+4%	+$388K	0.77%	46
2015 Q1	$10.8M	Buy	240,934 +26,186	+12%	+$1.09M	0.84%	47
2014 Q4	$8.04M	Buy	214,748 +22,765	+12%	+$834K	0.7%	50
2014 Q3	$6.7M	Buy	191,983 +4,639	+2%	+$166K	0.66%	55
2014 Q2	$6.61M	Sell	187,344 -4,771	-2%	-$159K	0.66%	54
2014 Q1	$6.26M	Buy	192,115 +49,097	+34%	+$1.88M	0.64%	55
2013 Q4	$6.03M	Buy	143,018 +108,878	+319%	+$4.48M	0.66%	49
2013 Q3	$1.36M	Buy	+34,140	New	+$1.43M	0.2%	46

Other funds holding HAE

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

AMI Asset Management's HAE Position: Q2 2016 in Review

AMI Asset Management sold out of Haemonetics (HAE) in Q2 2016, closing a stake of 376,283 shares — an estimated $13.2M sold.

AMI Asset Management first reported a position in HAE in Q3 2013 and held it in 11 quarters. The position peaked at $13.2M in Q1 2016. 177 funds tracked by Wall St. Rank hold HAE as of Q2 2016.

AMI Asset Management reported no remaining Haemonetics position as of Q2 2016 after selling out during the quarter.
AMI Asset Management sold 376,283 Haemonetics shares in Q2 2016, an estimated $13.2M.
AMI Asset Management first reported a position in Haemonetics in Q3 2013 and held it in 11 quarters.
AMI Asset Management's Haemonetics position peaked at $13.2M in Q1 2016.
177 funds tracked by Wall St. Rank held Haemonetics as of Q2 2016.

Based on AMI Asset Management's 13F filing for Q2 2016, filed 21 Jul 2016.